A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
Clinical trial NCT00320255 · COMPLETED
Trial details
- NCT number
- NCT00320255
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2009-01-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.